- Home
- EVH vs MLTX Comparison
EVH vs MLTX Comparison
Compare EVH & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVH
- MLTX
- Stock Information
- Founded
- EVH 2011
- MLTX 2021
- Country
- EVH United States
- MLTX Switzerland
- Employees
- EVH N/A
- MLTX N/A
- Industry
- EVH Other Consumer Services
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- EVH Consumer Discretionary
- MLTX Health Care
- Exchange
- EVH Nasdaq
- MLTX Nasdaq
- Market Cap
- EVH 1.0B
- MLTX 904.7M
- IPO Year
- EVH 2015
- MLTX N/A
- Fundamental
- Price
- EVH $4.29
- MLTX $13.44
- Analyst Decision
- EVH Strong Buy
- MLTX Buy
- Analyst Count
- EVH 14
- MLTX 9
- Target Price
- EVH $12.25
- MLTX $36.33
- AVG Volume (30 Days)
- EVH 5.5M
- MLTX 2.3M
- Earning Date
- EVH 11-06-2025
- MLTX 11-05-2025
- Dividend Yield
- EVH N/A
- MLTX N/A
- EPS Growth
- EVH N/A
- MLTX N/A
- EPS
- EVH N/A
- MLTX N/A
- Revenue
- EVH $2,054,052,000.00
- MLTX N/A
- Revenue This Year
- EVH N/A
- MLTX N/A
- Revenue Next Year
- EVH $27.90
- MLTX N/A
- P/E Ratio
- EVH N/A
- MLTX N/A
- Revenue Growth
- EVH N/A
- MLTX N/A
- 52 Week Low
- EVH $3.50
- MLTX $5.95
- 52 Week High
- EVH $13.62
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- EVH 32.73
- MLTX 48.90
- Support Level
- EVH $3.60
- MLTX $12.43
- Resistance Level
- EVH $4.55
- MLTX $13.99
- Average True Range (ATR)
- EVH 0.48
- MLTX 0.73
- MACD
- EVH 0.07
- MLTX 0.78
- Stochastic Oscillator
- EVH 28.73
- MLTX 86.99
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.